BIONOVO INC
DelistedCIK 1203957fmd_0VJQH1VE7FW3MF9PYQXBDCN9P3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2003 to Mar 31, 2012, 15 periods
| Line item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 0 | 1 | 0 |
| Research and development | – | – | – | – | – | – | 12 | 15 | 21 |
| Total operating expenses | – | – | – | – | – | – | 17 | 18 | 24 |
| Operating income | – | – | – | – | – | – | (16) | (18) | (24) |
| Interest expense | – | – | – | – | – | – | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | – | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | – | – | (0) | (0) | 10 |
| Income before taxes | – | – | – | – | – | – | (16) | (18) | (14) |
| Income tax expense | – | – | – | – | – | – | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | – | (16) | (18) | (14) |
| Net income | (0) | (1) | (4) | (6) | (13) | (17) | (16) | (18) | (14) |